BIO-MODELING SYSTEMS
Created in 2004
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
992 497Activities
Technologies
Entity types
Location
3 Rue de l'Arrivée, 75015 Paris, France
Paris
France
Employees
Scale: 11-50
Estimated: 5
SIREN
443633458Engaged corporates
10
1 8Added in Motherbase
5 years, 6 months ago
healthtech Value proposition
The Mechanisms-Based Medicine Company
Bio-Modeling Systems is the world’s first Mechanisms-Based medicine company that changed the discovery paradigm to create novel medical meanings from unreliable heterogeneous sources of data to generate validated & directly exploitable first in class heuristic non-mathematical mechanistic CADITM Discovery models.
We propose to R&D & Translational Medicine Executives, robust alternative decision-making to de-risk, save time, costs, and novel cost-effective diagnostics/therapies for their businesses.
Created in 2004, profitable since 2006, thanks to our recurrent clients, we confirmed with our partners CADITM Discovery capability to generate outstanding value through:
• Strong & long term strategic R&D collaborations (>100 people collaborating).
• Dual business model : Contractual or Collaborative R&D programs.
• External valorization of our collaborative R&D programs through out-licensing or spin-off.
• Outstanding internal pipeline of programs ready for collaborations, and
• Already 1 therapeutic spin-off, 1 exclusive out-license, 14 CADITM successes independently validated by our clients/partners, 4 issued patents and 10 publications (for all details www.bmsystems.net).
You have a question, we may have the ability to generate the answer through one of our 6 BMSystems’ solutions to critical & high impact issues.
• GO-NO GO decision before product acquisition or for portfolio risk analysis.
• GO-NO GO decision before next development phase.
• R&D program Rescue for a program facing critical issues during its lifetime.
• External R&D “B plan” program when the “A plan” cannot be rescued.
• Exploratory Discovery program to discover novel causal mechanism concept
• Novel Hypotheses discovery and novel thrapeutic and/or diagnostic solutions.
For more and latest information: www.bmsystems.net
In silico heuristic modeling, CNS discovery, Infectous diseases, Oncology discovery, Industrial biotech, Metabolism, dermatology, microbiotas, alzheimer's disease, Parkinson's disease, fibromyalgia, Chronic Fatigue Syndrome, Epigenetics, multiple scerosis, skincare, cosmetics, Nutrition, connected health, pain, migraine, heuristic, general semantic, psychiatry, neurology, Creutzfeld-Jacob, mechanisms-based medicine, medicine, translational medicine, Augmented intelligence, and Artificial IntelligenceOriginal language
The Mechanisms-Based Medicine Company
Bio-Modeling Systems is the world’s first Mechanisms-Based medicine company that changed the discovery paradigm to create novel medical meanings from unreliable heterogeneous sources of data to generate validated & directly exploitable first in class heuristic non-mathematical mechanistic CADITM Discovery models.
We propose to R&D & Translational Medicine Executives, robust alternative decision-making to de-risk, save time, costs, and novel cost-effective diagnostics/therapies for their businesses.
Created in 2004, profitable since 2006, thanks to our recurrent clients, we confirmed with our partners CADITM Discovery capability to generate outstanding value through:
• Strong & long term strategic R&D collaborations (>100 people collaborating).
• Dual business model : Contractual or Collaborative R&D programs.
• External valorization of our collaborative R&D programs through out-licensing or spin-off.
• Outstanding internal pipeline of programs ready for collaborations, and
• Already 1 therapeutic spin-off, 1 exclusive out-license, 14 CADITM successes independently validated by our clients/partners, 4 issued patents and 10 publications (for all details www.bmsystems.net).
You have a question, we may have the ability to generate the answer through one of our 6 BMSystems’ solutions to critical & high impact issues.
• GO-NO GO decision before product acquisition or for portfolio risk analysis.
• GO-NO GO decision before next development phase.
• R&D program Rescue for a program facing critical issues during its lifetime.
• External R&D “B plan” program when the “A plan” cannot be rescued.
• Exploratory Discovery program to discover novel causal mechanism concept
• Novel Hypotheses discovery and novel thrapeutic and/or diagnostic solutions.
For more and latest information: www.bmsystems.net
Understanding Disease Mechanisms | Bmsystems.org | France
https://www.bmsystems.org/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Cosmetic Valley Cosmetics, Public business cluster, French Cluster, Personal Care Product Manufacturing | Cosmetic Valley Cosmetics, Public business cluster, French Cluster, Personal Care Product Manufacturing | Not capitalistic Not partnership Event 17 Oct 2018 | | |
 Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Not partnership Event 9 Apr 2019 | | |
 Nestlé Food, Food and Beverage Services | Nestlé Food, Food and Beverage Services | Not capitalistic Partnership Event 22 Nov 2018 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Not capitalistic Not partnership Event 2 Nov 2016 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Not partnership Event 24 Oct 2018 | | |
 Orange Telecoms, Law Practice, Telecommunications | Orange Telecoms, Law Practice, Telecommunications | Not capitalistic Partnership Event 14 Jun 2018 | | |
 Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Not partnership Event 5 Apr 2019 | | |
 Danone Food, Food and Beverage Manufacturing | Danone Food, Food and Beverage Manufacturing | Not capitalistic Not partnership Event 11 Oct 2021 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Not capitalistic Not partnership Event 13 Nov 2018 | | |
 Swiss Life Insurance, Financial Services | Swiss Life Insurance, Financial Services | Not capitalistic Partnership Event 14 Oct 2019 | | |